Petrylak D.P.de Wit R.Chi K.N.Drakaki A.Sternberg C.N.Nishiyama H.Castellano D.Hussain S.A.Fl?chon A.Bamias A.Yu E.Y.Lee H.J.Park S.H.Rha S.Y.Kim Y.J.Lee Y.-G.Vazquez Cort?s L.Lorena Urzua Flores C.Blaisse R.J.B.Erdkamp F.L.G.Aarts M.J.B.van der Heijden M.S.Wojcik-Tomaszewska J.Tomczak P.Sikora-Kupis B.Schenker M.Herzal A.A.Udrea A.A.Karlov P.Fomkin R.Gajate Borau P.Grande E.Matsubara N.Delgado Mignorance J.I.Su Y.-L.Li J.-R.Lin C.-L.CHIA-CHI LINYeh S.-P.Erman M.Urun Y.Golovko Y.Bondarenko I.Alekseev B.Sinielnikov I.Crabb S.J.Syndikus I.Huddart R.Sundar S.Chowdhury S.Sarwar N.Flaig T.W.Pan C.X.Schwarz J.K.Necchi A.Cultrera J.L.Acs P.I.Hainsworth J.D.Herms B.T.Lawler W.E.Lowe T.E.G?czi L.Ou Y.-C.Coskun H.S.Su W.-P.Bedke J.Gakis G.Percent I.J.Lee J.-L.Tucci M.Semenov A.Laestadius F.Peer A.Tortora G.Safina S.Garcia del Muro X.Rodriguez-Vida A.Cicin I.Harputluoglu H.Tagawa S.T.Vaishampayan U.Aragon-Ching J.B.Hamid O.Liepa A.M.Wijayawardana S.Russo F.Walgren R.A.Zimmermann A.H.Hozak R.R.Bell-McGuinn K.M.Powles T.Wong S.-L.S.Tan T.H.Hovey E.J.Clay T.D.Wan Ng S.S.Rutten A.Machiels J.-P.Dumez H.Cheng S.Y.-S.Ferrario C.Sengeloev L.Jensen N.V.Thibault C.Laguerre B.Joly F.Culine S.Becht C.Niegisch G.St?ckle M.Grimm M.-O.Schwentner C.A.Schultze-Seemann W.Kalofonos H.Mavroudis D.Papandreou C.Karavasilis V.R?v?sz J.Rosenbaum E.Leibowitz-Amit R.Kejzman D.Sarid D.Scagliotti G.V.Bracarda S.Massari F.Osawa T.Miyajima N.Shinohara N.Fukuta F.Ohyama C.Obara W.Yamashita S.Tomita Y.Kawai K.Fukasawa S.Oyama M.Yonese J.Nagata M.Uemura M.Nishimura K.Kawakita M.Tsunemori H.Hashine K.Inokuchi J.Yokomizo A.Nagamori S.2022-09-152022-09-1520201470-2045https://www.scopus.com/inward/record.uri?eid=2-s2.0-85077147606&doi=10.1016%2fS1470-2045%2819%2930668-0&partnerID=40&md5=b45627a06edd945763663d8608578a3fhttps://scholars.lib.ntu.edu.tw/handle/123456789/620246Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trialjournal article10.1016/S1470-2045(19)30668-0317537272-s2.0-85077147606